Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
NCT05240352

Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression

Led by The University of Texas Health Science Center, Houston · Updated on 2026-02-18

45

Participants Needed

1

Research Sites

216 weeks

Total Duration

On this page

Sponsors

T

The University of Texas Health Science Center, Houston

Lead Sponsor

M

Milken Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to investigate whether transcranial direct-current stimulation (tDCS) will engage reward-related brain circuitry, more specifically the uncinate fasciculus (UF) tract, which connects the orbitofrontal cortex (OFC) and nucleus accumbens (NAcc) regions. Also to evaluate whether the changes in the fractional anisotropy (FA) of the UF tract are associated with changes of clinical symptoms of anhedonia and finally to investigate the moderation role of simulated electric fields (EFs) in an association between FA of the UF and symptoms of anhedonia.

CONDITIONS

Official Title

Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression

Who Can Participate

Age: 18Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Bipolar Disorder and clinically significant anhedonia
  • Mild symptoms of depression
Not Eligible

You will not qualify if you...

  • Substance abuse or dependence and any drug use (except alcohol or nicotine) in the past month before baseline
  • Personality disorder interfering with study participation as judged clinically
  • Previous neurological conditions such as epilepsy, traumatic brain injury, or stroke
  • Severe, life-threatening non-psychiatric medical conditions
  • Specific contraindications for tDCS like metallic plates in the head
  • Participants identified as acutely suicidal or severely agitated

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

J

Jair C Soares, MD,PhD

CONTACT

A

Alexandre P Diaz, MD,PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here